THW abrdn quarterly earnings reflect managements optimistic longterm outlook for global healthcare investment opportunities HTCO HighTrend posts solid core business segment results even as broader consumer spending headwinds persist VRDN Viridian Therapeutics notches narrow Q4 2025 EPS beat but shares fall 358 percent on lukewarm investor sentiment